Guillain–Barre Syndrome-Like Polyneuropathy Induced by Immune Checkpoint Inhibitors: A Case Report
Acta Neurologica Taiwanica · 2025
DOI: 10.4103/ant.ant_112_0090 ↗Kurz gefasst
Fallbericht in der Zeitschrift Acta Neurologica Taiwanica, 2025. Verfasst von Bo-Kang Cheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Guillain-Barre Syndrome, Nivolumab, Polyneuropathies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Over the past decade, immune checkpoint inhibitors (ICIs) have emerged as a crucial therapeutic option for treating various malignancies. Nivolumab, an ICI, is a monoclonal antibody directed against programmed cell death protein 1. However, many studies indicate that ICIs can lead to various immune-related adverse events (irAEs), with neurological irAEs accounting for approximately 1%–5% of these cases. Neurological adverse events such as Guillain–Barre syndrome (GBS) are rare but life threatening. This report presents the case of a 72-year-old male diagnosed with sarcomatoid squamous cell carcinoma of the trachea, who was admitted with rapid-onset weakness of the upper limbs 7 days following the latest nivolumab treatment. These symptoms progressed quickly to quadriplegia and respiratory failure, requiring intubation and mechanical ventilation. Serum antiganglioside antibodies were positive for immunoglobulin (Ig) M-GM1, IgM-GD1b, and IgG-GM3. His clinical symptoms improved significantly after steroid and intravenous immunoglobulin treatment. This rare and atypical case highlights the complexity of ICI-related GBS. Early recognition of associated symptoms is crucial for timely and appropriate treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Zitieren
APA
Cheng, B. K., Ko, C. A., Kuo, C. L., Nai, T. C., Lin, W., Chou, C. H., & Sung, Y. F. (2025). Guillain–Barre Syndrome-Like Polyneuropathy Induced by Immune Checkpoint Inhibitors: A Case Report. Acta Neurologica Taiwanica. https://doi.org/10.4103/ant.ant_112_0090
Vancouver
Cheng BK, Ko CA, Kuo CL, Nai TC, Lin W, Chou CH, et al. Guillain–Barre Syndrome-Like Polyneuropathy Induced by Immune Checkpoint Inhibitors: A Case Report. Acta Neurologica Taiwanica. 2025. doi:10.4103/ant.ant_112_0090
BibTeX
@article{Cheng2025,
author = {Cheng, Bo-Kang and Ko, Chien-An and Kuo, Chun-Lin and Nai, Te-Chi and Lin, Wei and Chou, Chung-Hsing and Sung, Yueh-Feng},
title = {Guillain–Barre Syndrome-Like Polyneuropathy Induced by Immune Checkpoint Inhibitors: A Case Report},
journal = {Acta Neurologica Taiwanica},
year = {2025},
doi = {10.4103/ant.ant_112_0090}
}
EUVIMED